Contact BubbleGen™ Support Every cell therapy research process is different. Partner with our team to identify how BubbleGen™ can help address your cell selection challenges and support your research program goals.

Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for for VueJect®, the First Dedicated Ultrasound Contrast Delivery System VueJect® strengthens Bracco's integrated CEUS ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging